Healthcare · Medical Devices · Ireland
As of 2026-04-17 · Source: yfinance · Market: closed_weekend · Cache TTL 360 min
| 1 Day | +0.63% |
| 1 Month | -1.17% |
| 3 Months | -10.61% |
| YTD | -10.27% |
| 1 Year | +5.37% |
| 52-Week High | $106.33 |
| 52-Week Low | $79.93 |
| Market Cap | $110,658,043,904 |
| P/E (Trailing) | 24.08 |
| P/E (Forward) | 14.22 |
| EPS (TTM) | $3.58 |
| Dividend Yield | 3.30% |
| Beta | 0.76 |
| Revenue (TTM) | $35,484,000,256 |
| Profit Margin | 13.00% |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-